SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
SERA PROGNOSTICS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$2.03−0.03 (-1.46%)
Close on Oct 19, 2026
- Market cap
- $102.47M
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$81.00KFY2025, +26.5% a year since FY2020